Skip to main content

The Haematology Research Group, led by Dr Freda Passam, will be investigating mechanisms of platelet hyperactivity in diabetes in collaboration with Dr Maggie Kalev-Zylinska, group leader in the Department of Molecular Medicine and Pathology, the University of Auckland (UoA), New Zealand.

Platelets are critical for the development of cardiovascular complications. The collaborative will investigate transcriptomic and proteomic signatures in platelet progenitors and platelets in diabetes to identify key pathways of platelet hyperactivity.

“This project will generate significant new knowledge, with the potential to identify therapeutic targets to prevent cardiovascular events in diabetes,” says Dr Passam.